Is DocuSign Stock Undervalued?
Digital signature software business DocuSign (NASDAQ:DOCU) has been struggling over…
Buy
69
ARTV Quote, Financials, Valuation and Earnings
Last price:
$4.30
Seasonality move
:
-1.06%
Day range:
$4.15 - $4.46
52-week range:
$1.47 - $11.55
Dividend yield:
0%
P/E ratio:
--
P/S ratio:
46.79x
P/B ratio:
0.81x
Volume:
284.5K
Avg. volume:
1.9M
1-year change:
-60.77%
Market cap:
$104.8M
Revenue:
$251K
EPS (TTM):
-$3.25
Earnings Data
Next earnings date for ARTV
--
Most recent earnings per share
-$0.88
Missed by $0.08
(Sep 30/2025)
Consensus Estimate
-$0.80
(Sep 30/2025)
SEE THE 1% OF STOCKS YOU NEED TO OWN FOR MASSIVE RETURNS
GET BETTER TRADE IDEAS
ARTV Quarterly Earnings History
| Date | Quarter | Revenue Forecast | Actual Revenue | Reported EPS | Consensus EPS | Beat/Miss |
|---|---|---|---|---|---|---|
| 12/31/2025 | Q4 | -- | -- | -- | -$0.80 | -- |
| 09/30/2025 | Q3 | -- | -- | -$0.88 | -$0.80 | -$0.08 |
| 08/07/2025 | Q2 | -- | -- | -$0.87 | -$0.77 | -$0.10 |
| 05/08/2025 | Q1 | -- | -- | -$0.83 | -$0.62 | -$0.21 |
| 03/24/2025 | Q4 | $50K | -- | -$0.66 | -$0.58 | -$0.08 |
| 11/12/2024 | Q3 | $75K | -- | -$0.92 | -$0.64 | -$0.29 |
| 08/29/2024 | Q2 | $75K | -- | -$0.62 | -$1.59 | $0.97 |
| 03/31/2024 | Q1 | -- | $251K | -$1.49 | -- | -- |
| 03/31/2023 | Q1 | -- | -- | -$0.95 | -- | -- |
| 03/31/2022 | Q1 | -- | -- | -$0.69 | -- | -- |
| 12/31/2021 | Q4 | -- | -- | -$0.65 | -- | -- |
| 03/31/2021 | Q1 | -- | -- | -$2.43 | -- | -- |
| 12/31/2020 | Q4 | -- | -- | -$0.34 | -- | -- |
Artiva Biotherapeutics, Inc. Earnings Questions
-
How Much did Artiva Biotherapeutics, Inc. Generate in Revenue Last Quarter?
Artiva Biotherapeutics, Inc. reported -- worth of top line sales in its most recent quarter.
-
Did Artiva Biotherapeutics, Inc. Beat Earnings Last Quarter?
Artiva Biotherapeutics, Inc. announced earnings per share of -$0.88 which represents a miss of analyst forecast a -$0.80 per share.
-
Is Artiva Biotherapeutics, Inc. Profitable?
Artiva Biotherapeutics, Inc. reported -$662K that represents -$0.03 per share over the last quarter.
-
What is the Analyst Consensus for Artiva Biotherapeutics, Inc. EPS Next Year?
Artiva Biotherapeutics, Inc.'s earnings are forecast to decrease from -$2.69 per share to -$5.08 per share next year representing a decrease of -14.82%.
-
When is Artiva Biotherapeutics, Inc.'s Earnings Date?
Currently, Artiva Biotherapeutics, Inc. has not yet stated when its earnings date is, however, based on past estimates it's likely to take place on March 26, 2026.
SEE THE 1% OF STOCKS YOU NEED TO OWN FOR MASSIVE RETURNS
GET BETTER TRADE IDEAS
Popular
Is SentinelOne Stock Undervalued?
Cybersecurity major SentinelOne (NYSE:S) has struggled over several years, delivering…
Is Broadcom Stock on Sale?
Chip and software maker Broadcom (NASDAQ:AVGO) has been among the…
Stock Ideas
Buy
57
Is NVDA Stock a Buy?
Market Cap: $4.6T
P/E Ratio: 64x
Buy
55
Is AAPL Stock a Buy?
Market Cap: $4T
P/E Ratio: 37x
Buy
61
Is GOOG Stock a Buy?
Market Cap: $3.8T
P/E Ratio: 39x
Alerts
Buy
80
TVTX alert for Dec 25
Travere Therapeutics, Inc. [TVTX] is up 14.03% over the past day.
Buy
68
KOD alert for Dec 25
Kodiak Sciences, Inc. [KOD] is up 13.41% over the past day.
Buy
64
ZCSH alert for Dec 25
Grayscale Zcash Trust (ZEC) [ZCSH] is up 5.33% over the past day.
